NCT02216435View on ClinicalTrials.gov

Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 22, 2021

Study Completion Date

February 22, 2021

Conditions
Parkinson's Disease
Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02216435 - Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata | Biotech Hunter | Biotech Hunter